
Janus Henderson Global Life Sciences Fund Class S
JFNSX
Updated: 22/09/2026, 21:43:02
The Janus Henderson Global Life Sciences Fund Class S endeavors to achieve substantial capital appreciation over the long term. Its primary strategy involves allocating a minimum of 80% of its net assets (including any borrowed capital utilized for investment purposes) to businesses that its portfolio managers identify as having a strong life science orientation. Furthermore, as a foundational commitment to this focus, the fund has a fundamental policy to typically allocate at least 25% of its total assets to securities issued by companies formally classified within the "life sciences" sector.
No summaries found.
- Share price
- $83.50
- Market cap
- $5.91B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 06/07/2009
- Beta
- 0.66
- Last dividend
- $0.00
- Day range
- $83.50 – $83.50
- 52-week range
- $65.08 – $88.82
- 1-day performance
- 0.43%
- 1-year performance
- 28.30%
- Current drawdown (1Y)
- -5.99%
- CIK
- 0000277751
- CUSIP
- 471023457
- ISIN
- US4710234570
- Created
- 07/12/2025, 04:50:56
- Last update
- 22/09/2026, 21:43:02
Track Janus Henderson Global Life Sciences Fund Class S with an AI analyst
See which prediction-market events move JFNSX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.